Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

Nanotechnology has been extensively studied and exploited for cancer treatment as nanoparticles can play a significant role as a drug delivery system. Compared to conventional drugs, nanoparticle-based drug delivery has specific advantages, such as improved stability and biocompatibility, enhanced p...

Full description

Bibliographic Details
Main Authors: Yihan Yao, Yunxiang Zhou, Lihong Liu, Yanyan Xu, Qiang Chen, Yali Wang, Shijie Wu, Yongchuan Deng, Jianmin Zhang, Anwen Shao
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmolb.2020.00193/full
id doaj-72a6720bc25d48e2b4cb0451d3b1f11f
record_format Article
spelling doaj-72a6720bc25d48e2b4cb0451d3b1f11f2020-11-25T03:38:39ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2020-08-01710.3389/fmolb.2020.00193558493Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug ResistanceYihan Yao0Yunxiang Zhou1Lihong Liu2Yanyan Xu3Yanyan Xu4Qiang Chen5Yali Wang6Shijie Wu7Yongchuan Deng8Jianmin Zhang9Anwen Shao10Department of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Radiation Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaSchool of Pharmacy, Nanjing Medical University, Nanjing, ChinaKey Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaCancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaNanotechnology has been extensively studied and exploited for cancer treatment as nanoparticles can play a significant role as a drug delivery system. Compared to conventional drugs, nanoparticle-based drug delivery has specific advantages, such as improved stability and biocompatibility, enhanced permeability and retention effect, and precise targeting. The application and development of hybrid nanoparticles, which incorporates the combined properties of different nanoparticles, has led this type of drug-carrier system to the next level. In addition, nanoparticle-based drug delivery systems have been shown to play a role in overcoming cancer-related drug resistance. The mechanisms of cancer drug resistance include overexpression of drug efflux transporters, defective apoptotic pathways, and hypoxic environment. Nanoparticles targeting these mechanisms can lead to an improvement in the reversal of multidrug resistance. Furthermore, as more tumor drug resistance mechanisms are revealed, nanoparticles are increasingly being developed to target these mechanisms. Moreover, scientists have recently started to investigate the role of nanoparticles in immunotherapy, which plays a more important role in cancer treatment. In this review, we discuss the roles of nanoparticles and hybrid nanoparticles for drug delivery in chemotherapy, targeted therapy, and immunotherapy and describe the targeting mechanism of nanoparticle-based drug delivery as well as its function on reversing drug resistance.https://www.frontiersin.org/article/10.3389/fmolb.2020.00193/fullnanoparticledrug deliveryhybrid nanoparticlestargeted cancer therapydrug resistance
collection DOAJ
language English
format Article
sources DOAJ
author Yihan Yao
Yunxiang Zhou
Lihong Liu
Yanyan Xu
Yanyan Xu
Qiang Chen
Yali Wang
Shijie Wu
Yongchuan Deng
Jianmin Zhang
Anwen Shao
spellingShingle Yihan Yao
Yunxiang Zhou
Lihong Liu
Yanyan Xu
Yanyan Xu
Qiang Chen
Yali Wang
Shijie Wu
Yongchuan Deng
Jianmin Zhang
Anwen Shao
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Frontiers in Molecular Biosciences
nanoparticle
drug delivery
hybrid nanoparticles
targeted cancer therapy
drug resistance
author_facet Yihan Yao
Yunxiang Zhou
Lihong Liu
Yanyan Xu
Yanyan Xu
Qiang Chen
Yali Wang
Shijie Wu
Yongchuan Deng
Jianmin Zhang
Anwen Shao
author_sort Yihan Yao
title Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
title_short Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
title_full Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
title_fullStr Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
title_full_unstemmed Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
title_sort nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance
publisher Frontiers Media S.A.
series Frontiers in Molecular Biosciences
issn 2296-889X
publishDate 2020-08-01
description Nanotechnology has been extensively studied and exploited for cancer treatment as nanoparticles can play a significant role as a drug delivery system. Compared to conventional drugs, nanoparticle-based drug delivery has specific advantages, such as improved stability and biocompatibility, enhanced permeability and retention effect, and precise targeting. The application and development of hybrid nanoparticles, which incorporates the combined properties of different nanoparticles, has led this type of drug-carrier system to the next level. In addition, nanoparticle-based drug delivery systems have been shown to play a role in overcoming cancer-related drug resistance. The mechanisms of cancer drug resistance include overexpression of drug efflux transporters, defective apoptotic pathways, and hypoxic environment. Nanoparticles targeting these mechanisms can lead to an improvement in the reversal of multidrug resistance. Furthermore, as more tumor drug resistance mechanisms are revealed, nanoparticles are increasingly being developed to target these mechanisms. Moreover, scientists have recently started to investigate the role of nanoparticles in immunotherapy, which plays a more important role in cancer treatment. In this review, we discuss the roles of nanoparticles and hybrid nanoparticles for drug delivery in chemotherapy, targeted therapy, and immunotherapy and describe the targeting mechanism of nanoparticle-based drug delivery as well as its function on reversing drug resistance.
topic nanoparticle
drug delivery
hybrid nanoparticles
targeted cancer therapy
drug resistance
url https://www.frontiersin.org/article/10.3389/fmolb.2020.00193/full
work_keys_str_mv AT yihanyao nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance
AT yunxiangzhou nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance
AT lihongliu nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance
AT yanyanxu nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance
AT yanyanxu nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance
AT qiangchen nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance
AT yaliwang nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance
AT shijiewu nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance
AT yongchuandeng nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance
AT jianminzhang nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance
AT anwenshao nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance
_version_ 1724541275505426432